1st Feb 2016 07:14
LONDON (Alliance News) - Medical devices manufacturer Smith & Nephew PLC on Monday said Chief Executive Olivier Bohuon has been diagnosed with a treatable form of cancer.
The FTSE 100-listed company said Bohuon will continue to handle his CEO duties during the majority of his treatment period, which is due to start later this month and be completed by the late autumn.
The group has, however, approved provisional governance procedures to ensure the group operates effectively during his treatment period, including Robert Quarta, Smith & Nephew's chairman, taking on executive oversight if required.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Smith & Nephew